TherapeuticsMD TXMD Stock
TherapeuticsMD Price Chart
TherapeuticsMD TXMD Financial and Trading Overview
| TherapeuticsMD stock price | 2.02 USD |
| Previous Close | 2.01 USD |
| Open | 2.01 USD |
| Bid | 1.72 USD x 100 |
| Ask | 2.4 USD x 100 |
| Day's Range | 2.01 - 2.06 USD |
| 52 Week Range | 1.03 - 2.95 USD |
| Volume | 2.99K USD |
| Avg. Volume | 24.22K USD |
| Market Cap | 23.78M USD |
| Beta (5Y Monthly) | 0.649 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.04 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
TXMD Valuation Measures
| Enterprise Value | 19.64M USD |
| Trailing P/E | N/A |
| Forward P/E | 5.8708572 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 7.2730885 |
| Price/Book (mrq) | 0.88188845 |
| Enterprise Value/Revenue | 6.005 |
| Enterprise Value/EBITDA | -14.343 |
Trading Information
TherapeuticsMD Stock Price History
| Beta (5Y Monthly) | 0.649 |
| 52-Week Change | 86.11% |
| S&P500 52-Week Change | 15.77% |
| 52 Week High | 2.95 USD |
| 52 Week Low | 1.03 USD |
| 50-Day Moving Average | 2.11 USD |
| 200-Day Moving Average | 2.11 USD |
TXMD Share Statistics
| Avg. Volume (3 month) | 24.22K USD |
| Avg. Daily Volume (10-Days) | 14.52K USD |
| Shares Outstanding | 11.57M |
| Float | 9.49M |
| Short Ratio | 0.75 |
| % Held by Insiders | 9.03% |
| % Held by Institutions | 31.73% |
| Shares Short | 26.44K |
| Short % of Float | 0.32% |
| Short % of Shares Outstanding | 0.22% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -6.63% |
| Operating Margin (ttm) | -32.22% |
| Gross Margin | 100.00% |
| EBITDA Margin | -41.86% |
Management Effectiveness
| Return on Assets (ttm) | -2.87% |
| Return on Equity (ttm) | -1.084% |
Income Statement
| Revenue (ttm) | 3.27M USD |
| Revenue Per Share (ttm) | 0.28 USD |
| Quarterly Revenue Growth (yoy) | -8.69% |
| Gross Profit (ttm) | 3.27M USD |
| EBITDA | -1369000 USD |
| Net Income Avi to Common (ttm) | -295000 USD |
| Diluted EPS (ttm) | -0.04 |
| Quarterly Earnings Growth (yoy) | -71.89% |
Balance Sheet
| Total Cash (mrq) | 9.19M USD |
| Total Cash Per Share (mrq) | 0.79 USD |
| Total Debt (mrq) | 5.56M USD |
| Total Debt/Equity (mrq) | 20.49 USD |
| Current Ratio (mrq) | 3.222 |
| Book Value Per Share (mrq) | 2.33 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 3.12M USD |
| Levered Free Cash Flow (ttm) | 896.63K USD |
Profile of TherapeuticsMD
| Country | United States |
| State | FL |
| City | Boca Raton |
| Address | 951 Yamato Road |
| ZIP | 33431 |
| Phone | 561 961 1900 |
| Website | https://www.therapeuticsmd.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 1 |
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system. The company also offers prescription prenatal vitamin products under the BocaGreenMD and vitaMedMD brand names. It has a license agreement with Mayne Pharma Group Limited. The company sells its products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Q&A For TherapeuticsMD Stock
What is a current TXMD stock price?
TherapeuticsMD TXMD stock price today per share is 2.02 USD.
How to purchase TherapeuticsMD stock?
You can buy TXMD shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for TherapeuticsMD?
The stock symbol or ticker of TherapeuticsMD is TXMD.
Which industry does the TherapeuticsMD company belong to?
The TherapeuticsMD industry is Drug Manufacturers - Specialty & Generic.
How many shares does TherapeuticsMD have in circulation?
The max supply of TherapeuticsMD shares is 11.57M.
What is TherapeuticsMD Price to Earnings Ratio (PE Ratio)?
TherapeuticsMD PE Ratio is now.
What was TherapeuticsMD earnings per share over the trailing 12 months (TTM)?
TherapeuticsMD EPS is -0.04 USD over the trailing 12 months.
Which sector does the TherapeuticsMD company belong to?
The TherapeuticsMD sector is Healthcare.
TherapeuticsMD TXMD included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
27599.79 USD — |
+0.45
|
7.61B USD — | 27592.56 USD — | 27722.75 USD — | — - | 7.61B USD — |
|
US Tech Health Care
IXHC
US
|
1292.45 USD — |
-2.09
|
— — | 1285.97 USD — | 1330.32 USD — | — - | — — |
|
US Tech Global Select Market Com
NQGS
US
|
13588.38 USD — |
+0.48
|
— — | 13584.53 USD — | 13647.9 USD — | — - | — — |
- {{ link.label }} {{link}}
